Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing

Disorders involving β-globin gene mutations, primarily β-thalassemia and sickle cell disease, represent a major target for hematopoietic stem/progenitor cell (HSPC) gene therapy. This includes CRISPR/Cas9-mediated genome editing approaches in adult CD34(+) cells aimed toward the reactivation of feta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Li, Chang, Psatha, Nikoletta, Sova, Pavel, Gil, Sucheol, Wang, Hongjie, Kim, Jiho, Kulkarni, Chandana, Valensisi, Cristina, Hawkins, R. David, Stamatoyannopoulos, George, Lieber, André
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2018
Materias:
Gene Therapy
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6024639/
https://ncbi.nlm.nih.gov/pubmed/29789357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-03-838540
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares